Published in J Am Chem Soc on October 06, 2011
A signal-on fluorosensor based on quench-release principle for sensitive detection of antibiotic rapamycin. Biosensors (Basel) (2015) 0.87
The covalent trimethoprim chemical tag facilitates single molecule imaging with organic fluorophores. Biophys J (2014) 0.82
Ultra Q-bodies: quench-based antibody probes that utilize dye-dye interactions with enhanced antigen-dependent fluorescence. Sci Rep (2014) 0.81
Strategy for making a superior Quenchbody to proteins: effect of the fluorophore position. Sensors (Basel) (2014) 0.78
Plasma anti-α-galactoside antibody binds to serine- and threonine-rich peptide sequence of apo(a) subunit in Lp(a). Glycoconj J (2014) 0.77
Equilibrium and dynamic design principles for binding molecules engineered for reagentless biosensors. Anal Biochem (2014) 0.76
A High-Performance Fluorescence Immunoassay Based on the Relaxation of Quenching, Exemplified by Detection of Cardiac Troponin I. Sensors (Basel) (2016) 0.75
Cell-free measurements of brightness of fluorescently labeled antibodies. Sci Rep (2017) 0.75
Biomolecular engineering for nanobio/bionanotechnology. Nano Converg (2017) 0.75
Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling. Nat Med (2004) 2.71
TRPM1 is a component of the retinal ON bipolar cell transduction channel in the mGluR6 cascade. Proc Natl Acad Sci U S A (2009) 2.20
SIK2 is a key regulator for neuronal survival after ischemia via TORC1-CREB. Neuron (2011) 2.03
Dental changes evaluated with a 3D computer-assisted model analysis after long-term tongue retaining device wear in OSA patients. Sleep Breath (2008) 2.02
Cord blood transplantation combined with rituximab for Wiskott-Aldrich syndrome with autoimmune thrombotic thrombocytopenic purpura. J Allergy Clin Immunol (2013) 2.00
Farnesyl pyrophosphate regulates adipocyte functions as an endogenous PPARγ agonist. Biochem J (2011) 1.49
Single-molecule analysis of epidermal growth factor binding on the surface of living cells. EMBO J (2006) 1.45
Circumstances and outcomes of out-of-hospital cardiac arrest in elementary and middle school students in the era of public-access defibrillation. Circ J (2014) 1.38
Epigenetic gene silencing underlies C-fiber dysfunctions in neuropathic pain. J Neurosci (2010) 1.31
FRET analysis of protein conformational change through position-specific incorporation of fluorescent amino acids. Nat Methods (2006) 1.31
Novel expression of vanilloid receptor 1 on capsaicin-insensitive fibers accounts for the analgesic effect of capsaicin cream in neuropathic pain. J Pharmacol Exp Ther (2003) 1.30
Inhibition of paclitaxel-induced A-fiber hypersensitization by gabapentin. J Pharmacol Exp Ther (2006) 1.24
Oral health, general health, and quality of life in older people. Spec Care Dentist (2008) 1.24
Sphingosine kinase isoforms regulate oxaliplatin sensitivity of human colon cancer cells through ceramide accumulation and Akt activation. J Biol Chem (2009) 1.17
Anatomical and physiological evidence for involvement of tuberoinfundibular peptide of 39 residues in nociception. Proc Natl Acad Sci U S A (2002) 1.14
Urban poverty: an urgent public health issue. J Urban Health (2007) 1.14
Input-output relationship in galvanotactic response of Dictyostelium cells. Biosystems (2006) 1.14
TRPM1: a vertebrate TRP channel responsible for retinal ON bipolar function. Cell Calcium (2010) 1.13
Autotaxin, a synthetic enzyme of lysophosphatidic acid (LPA), mediates the induction of nerve-injured neuropathic pain. Mol Pain (2008) 1.13
Multiple-state reactions between the epidermal growth factor receptor and Grb2 as observed by using single-molecule analysis. Proc Natl Acad Sci U S A (2007) 1.13
Riluzole enhances expression of brain-derived neurotrophic factor with consequent proliferation of granule precursor cells in the rat hippocampus. FASEB J (2002) 1.12
Locus-specific rescue of GluRepsilon1 NMDA receptors in mutant mice identifies the brain regions important for morphine tolerance and dependence. J Neurosci (2003) 1.12
Sildenafil for primary and secondary pulmonary hypertension. Clin Pharmacol Ther (2002) 1.11
Loss of peripheral morphine analgesia contributes to the reduced effectiveness of systemic morphine in neuropathic pain. J Pharmacol Exp Ther (2004) 1.11
Switching direction in electric-signal-induced cell migration by cyclic guanosine monophosphate and phosphatidylinositol signaling. Proc Natl Acad Sci U S A (2009) 1.11
Stratification of pediatric heart failure on the basis of neurohormonal and cardiac autonomic nervous activities in patients with congenital heart disease. Circulation (2003) 1.09
Abnormalities of neurohormonal and cardiac autonomic nervous activities relate poorly to functional status in fontan patients. Circulation (2004) 1.09
Pneumocystis jiroveci pneumonia in patients with rheumatoid arthritis treated with infliximab: a retrospective review and case-control study of 21 patients. Arthritis Rheum (2009) 1.09
Morphine-induced chemotaxis and brain-derived neurotrophic factor expression in microglia. J Neurosci (2005) 1.07
Elevated levels of high-sensitivity C-reactive protein and serum amyloid-A late after Kawasaki disease: association between inflammation and late coronary sequelae in Kawasaki disease. Circulation (2004) 1.05
Random insertion and deletion of arbitrary number of bases for codon-based random mutation of DNAs. Nat Biotechnol (2002) 1.03
Serum anti-myomegalin antibodies in patients with esophageal squamous cell carcinoma. Int J Oncol (2007) 1.03
A nontoxic chimeric enterotoxin adjuvant induces protective immunity in both mucosal and systemic compartments with reduced IgE antibodies. J Infect Dis (2002) 1.03
Downregulation of SIK2 expression promotes the melanogenic program in mice. Pigment Cell Melanoma Res (2010) 1.02
Immune responses against human papillomavirus (HPV) infection and evasion of host defense in cervical cancer. J Infect Chemother (2012) 1.00
Olfactory imprinting of amino acids in lacustrine sockeye salmon. PLoS One (2010) 1.00
Autotaxin and lysophosphatidic acid1 receptor-mediated demyelination of dorsal root fibers by sciatic nerve injury and intrathecal lysophosphatidylcholine. Mol Pain (2010) 1.00
Development of an orexin-2 receptor selective agonist, [Ala(11), D-Leu(15)]orexin-B. Bioorg Med Chem Lett (2003) 0.99
Increased expression of vanilloid receptor 1 on myelinated primary afferent neurons contributes to the antihyperalgesic effect of capsaicin cream in diabetic neuropathic pain in mice. J Pharmacol Exp Ther (2003) 0.99
Single-molecule analysis of epidermal growth factor signaling that leads to ultrasensitive calcium response. Biophys J (2005) 0.98
Characterization of three different sensory fibers by use of neonatal capsaicin treatment, spinal antagonism and a novel electrical stimulation-induced paw flexion test. Mol Pain (2006) 0.97
Photoswitching of peroxidase activity by position-specific incorporation of a photoisomerizable non-natural amino acid into horseradish peroxidase. FEBS Lett (2002) 0.96
Emerging functions for tuberoinfundibular peptide of 39 residues. Trends Endocrinol Metab (2003) 0.96
Noncompetitive detection of low molecular weight peptides by open sandwich immunoassay. Anal Chem (2007) 0.96
Neuropathy-specific analgesic action of intrathecal nicotinic agonists and its spinal GABA-mediated mechanism. Brain Res (2002) 0.96
Pharmacological switch in Abeta-fiber stimulation-induced spinal transmission in mice with partial sciatic nerve injury. Mol Pain (2008) 0.95
Lysophosphatidic acid-3 receptor-mediated feed-forward production of lysophosphatidic acid: an initiator of nerve injury-induced neuropathic pain. Mol Pain (2009) 0.95
Switching of bradykinin-mediated nociception following partial sciatic nerve injury in mice. J Pharmacol Exp Ther (2003) 0.95
Evidence for de novo synthesis of lysophosphatidic acid in the spinal cord through phospholipase A2 and autotaxin in nerve injury-induced neuropathic pain. J Pharmacol Exp Ther (2010) 0.95
Four-base codon-mediated incorporation of non-natural amino acids into proteins in a eukaryotic cell-free translation system. J Biosci Bioeng (2005) 0.94
Chaperone-assisted folding of a single-chain antibody in a reconstituted translation system. Biochem Biophys Res Commun (2004) 0.94
Cyclic RGD peptide-labeled upconversion nanophosphors for tumor cell-targeted imaging. Biochem Biophys Res Commun (2009) 0.94
Nasal pressure recordings to detect obstructive sleep apnea. Sleep Breath (2006) 0.93
In vivo plaque composition and morphology in coronary artery lesions in adolescents and young adults long after Kawasaki disease: a virtual histology-intravascular ultrasound study. Circulation (2009) 0.93
LPA-mediated demyelination in ex vivo culture of dorsal root. Neurochem Int (2006) 0.92
Position-specific incorporation of a fluorophore-quencher pair into a single streptavidin through orthogonal four-base codon/anticodon pairs. J Am Chem Soc (2002) 0.92
NSAID zaltoprofen possesses novel anti-nociceptive mechanism through blockage of B2-type bradykinin receptor in nerve endings. Neurosci Lett (2006) 0.91
The algogenic-induced nociceptive flexion test in mice: studies on sensitivity of the test and stress on animals. Brain Res Bull (2003) 0.91
Antinociceptive effect of cyclic phosphatidic acid and its derivative on animal models of acute and chronic pain. Mol Pain (2011) 0.90
Prolonged gabapentin analgesia in an experimental mouse model of fibromyalgia. Mol Pain (2008) 0.90
Tonic inhibitory role of alpha4beta2 subtype of nicotinic acetylcholine receptors on nociceptive transmission in the spinal cord in mice. Pain (2006) 0.90
Importance of terminal residues on circularly permutated Escherichia coli alkaline phosphatase with high specific activity. J Biosci Bioeng (2005) 0.90
Bovine insulin filaments induced by reducing disulfide bonds show a different morphology, secondary structure, and cell toxicity from intact insulin amyloid fibrils. Biophys J (2009) 0.89
Possible mechanisms by which adipocyte lipolysis is enhanced in exercise-trained rats. Biochem Biophys Res Commun (2002) 0.89
Evidence for lysophosphatidic acid 1 receptor signaling in the early phase of neuropathic pain mechanisms in experiments using Ki-16425, a lysophosphatidic acid 1 receptor antagonist. J Neurochem (2009) 0.89
Necessity of lysophosphatidic acid receptor 1 for development of arthritis. Arthritis Rheum (2013) 0.89
Detection of protein-protein interaction by bioluminescence resonance energy transfer from firefly luciferase to red fluorescent protein. J Biosci Bioeng (2002) 0.89
Characterization of neuropeptide Y (NPY) Y5 receptor-mediated obesity in mice: chronic intracerebroventricular infusion of D-Trp(34)NPY. Endocrinology (2003) 0.89
Next-generation sequencing coupled with a cell-free display technology for high-throughput production of reliable interactome data. Sci Rep (2012) 0.88
Downregulation of P2X3 receptor-dependent sensory functions in A/J inbred mouse strain. Eur J Neurosci (2002) 0.88
Involvement of LPA1 receptor signaling in the reorganization of spinal input through Abeta-fibers in mice with partial sciatic nerve injury. Mol Pain (2008) 0.88
Open sandwich-based immuno-transistor for label-free and noncompetitive detection of low molecular weight antigen. Anal Chem (2009) 0.87
A neuropeptide Y Y5 antagonist selectively ameliorates body weight gain and associated parameters in diet-induced obese mice. Proc Natl Acad Sci U S A (2006) 0.87
In vivo pain-inhibitory role of nociceptin/orphanin FQ in spinal cord. J Pharmacol Exp Ther (2003) 0.87
Creation of a thermostable firefly luciferase with pH-insensitive luminescent color. Photochem Photobiol (2003) 0.87
Gi2 signaling enhances proliferation of neural progenitor cells in the developing brain. J Biol Chem (2004) 0.87
Incorporation of fluorescent non-natural amino acids into N-terminal tag of proteins in cell-free translation and its dependence on position and neighboring codons. J Biosci Bioeng (2010) 0.86
Behavioral responses by migratory chum salmon to amino acids in natal stream water. Zoolog Sci (2009) 0.86
Calpain-mediated down-regulation of myelin-associated glycoprotein in lysophosphatidic acid-induced neuropathic pain. J Neurochem (2010) 0.86
Curcumin blocks chronic morphine analgesic tolerance and brain-derived neurotrophic factor upregulation. Neuroreport (2009) 0.86
Human IgG1 expression in silkworm larval hemolymph using BmNPV bacmids and its N-linked glycan structure. J Biotechnol (2008) 0.86
Formation of highly toxic soluble amyloid beta oligomers by the molecular chaperone prefoldin. FEBS J (2008) 0.86
EMG telemetry studies on upstream migration of chum salmon in the Toyohira River, Hokkaido, Japan. Fish Physiol Biochem (2011) 0.86
Life with and without heart disease among women and men over 50. J Women Aging (2008) 0.85
Detection of vimentin serine phosphorylation by multicolor Quenchbodies. Biosens Bioelectron (2012) 0.85
Microglial activation mediates de novo lysophosphatidic acid production in a model of neuropathic pain. J Neurochem (2010) 0.85
Open-sandwich enzyme immunoassay for one-step noncompetitive detection of corticosteroid 11-deoxycortisol. Anal Chem (2009) 0.85
Profiling of BoNT/C3-reversible gene expression induced by lysophosphatidic acid: ephrinB1 gene up-regulation underlying neuropathic hyperalgesia and allodynia. Neurochem Int (2008) 0.85
Simultaneous stimulation of spinal NK1 and NMDA receptors produces LPC which undergoes ATX-mediated conversion to LPA, an initiator of neuropathic pain. J Neurochem (2008) 0.85
Thoracoscopic esophagectomy and hand-assisted laparoscopic gastric mobilization for esophageal cancer with situs inversus totalis. J Gastrointest Surg (2011) 0.85
Importance of a CDR H3 basal residue in V(H)/V(L) interaction of human antibodies. J Biochem (2002) 0.84
An LPA species (18:1 LPA) plays key roles in the self-amplification of spinal LPA production in the peripheral neuropathic pain model. Mol Pain (2013) 0.84
Olfactory homing of chum salmon to stable compositions of amino acids in natal stream water. Zoolog Sci (2013) 0.84
Nocistatin and prepro-nociceptin/orphanin FQ 160-187 cause nociception through activation of Gi/o in capsaicin-sensitive and of Gs in capsaicin-insensitive nociceptors, respectively. J Pharmacol Exp Ther (2003) 0.84
Luminescent and substrate binding activities of firefly luciferase N-terminal domain. Biochim Biophys Acta (2003) 0.84
Loss of spinal substance P pain transmission under the condition of LPA1 receptor-mediated neuropathic pain. Mol Pain (2006) 0.84